Vivani Medical to Present at the ThinkEquity Investor Conference

by Business Wire • 2022/10/17 • 0 Comments

EMERYVILLE, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an innovative, clinical-stage biopharmaceutical company that develops novel, long-term therapeutic implants, announced today that it will present at the upcoming ThinkEquity investor conference at 11:00 am EDT at the Mandarin Oriental in New York on October 26, 2022. Dr. Adam Mendelsohn, CEO, will present a company overview and Brigid Makes, CFO, will join in hosting one-on-one meetings with in

← VIDEO: Tecnis Synergy ideal for patients who aim for full spectacle independence

Patrick Healy, a Senior Biopharma Executive with a Successful Track Record in Clinical Trials Development, joins Aviceda Therapeutics as Chief Operations Officer →

Post navigation